Albert Bourla, Pfizer CEO (Laurent Gillieron/Keystone via AP Images)

Pfiz­er shifts full port­fo­lio to non-prof­it mod­el in 45 low­er-in­come coun­tries

Pfiz­er is dou­bling down on its ef­forts to ad­dress health in­equities, shift­ing its full port­fo­lio to a not-for-prof­it mod­el in 45 low­er-in­come coun­tries.

The move builds on Pfiz­er’s “An Ac­cord for a Health­i­er World” ini­tia­tive launched back in May to in­crease ac­cess to the phar­ma gi­ant’s drugs and vac­cines. While the ini­tial pledge on­ly in­clud­ed 23 patent­ed prod­ucts avail­able in the US and EU, the lat­est com­mit­ment cov­ers all on- and off-patent brands, bring­ing the to­tal of­fer­ing to about 500 prod­ucts.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.